Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Abdel Wahab

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Leukemia|November 14, 2012
The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigeneticsO Abdel-Wahab, A Dey
Leukemia|July 3, 2010
The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alterationO Abdel-Wahab, O Kilpivaara, J Patel, et al.
Leukemia|April 27, 2011
DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, R Rampal, et al.
Annales De Chirurgie Plastique Et Esthetique|December 24, 2011
[Dermatofibrosarcoma protuberans in children]O Abdel Wahab, A Qassemyar, M Maillet, et al.
Leukemia|April 2, 2011
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, J Patel, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Leukemia|March 20, 2009
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AMLA Tefferi, K-H Lim, O Abdel-Wahab, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Leukemia|March 17, 2015
Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemiaR B Walter, M Othus, E M Paietta, et al.
Leukemia|February 5, 2015
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibitionL Chen, W Chen, M Mysliwski, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Leukemia|November 14, 2012
The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigeneticsO Abdel-Wahab, A Dey
Leukemia|July 3, 2010
The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alterationO Abdel-Wahab, O Kilpivaara, J Patel, et al.
Leukemia|April 27, 2011
DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, R Rampal, et al.
Annales De Chirurgie Plastique Et Esthetique|December 24, 2011
[Dermatofibrosarcoma protuberans in children]O Abdel Wahab, A Qassemyar, M Maillet, et al.
Leukemia|April 2, 2011
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasmsO Abdel-Wahab, A Pardanani, J Patel, et al.
Leukemia|August 24, 2011
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activityM M Reddy, M S Fernandes, A Deshpande, et al.
Leukemia|March 20, 2009
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AMLA Tefferi, K-H Lim, O Abdel-Wahab, et al.
Leukemia|March 6, 2009
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlatesA Tefferi, R L Levine, K-H Lim, et al.
Leukemia|March 17, 2015
Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemiaR B Walter, M Othus, E M Paietta, et al.
Leukemia|February 5, 2015
Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibitionL Chen, W Chen, M Mysliwski, et al.
Pageof 3